ResMed (RMD) net assets (shareholders' equity)

Net assets · fiscal 2026
$6.59B

ResMed (RMD) had net assets of $6.59B at the end of fiscal 2026 (June 30, 2026). That is 10.3% higher than the $5.97B of fiscal 2025. Figures as of 19 Nov 2026, 04:59 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2026
$6.59B
Change on fiscal 2025
+10.3%
Growth, 5 years
+17.9% a year
Growth, 10 years
+14.5% a year
Highest on record
$6.59Bfiscal 2026
Lowest on record
$1.12Bfiscal 2009
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ResMed net assets (shareholders' equity), in more detail

Over the five fiscal years to 2026 net assets grew at a compound 17.9% a year; over ten years the rate was 14.5% a year. Across the 18 fiscal years on record (2009–2026), the highest was $6.59B in fiscal 2026 and the lowest $1.12B in fiscal 2009.

History · 18 fiscal years

Net assets by fiscal year

ResMed net assets (shareholders' equity), year by year

ResMed (RMD) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2026$6.59B 10.3% up
2025$5.97B 22.7% up
2024$4.86B 17.8% up
2023$4.13B 22.9% up
2022$3.36B 16.5% up
2021$2.89B 15.6% up
2020$2.50B 20.5% up
2019$2.07B 0.6% up
2018$2.06B 5.0% up
2017$1.96B 15.7% up
2016$1.69B 6.8% up
2015$1.59B 9.7% down
2014$1.76B 9.2% up
2013$1.61B 0.2% up
2012$1.61B 7.1% down
2011$1.73B 34.4% up
2010$1.29B 15.5% up
2009$1.12B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of ResMed and comparable companies
CompanyNet assetsFiscal year
Mettler-Toledo International MTD-$23.64M2025
Centene CNC$19.95B2025
Genmab GMAB$5.85B2025
Illumina ILMN$2.72B2025
ResMed RMD$6.59B2026
Zoetis ZTS$3.33B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RMD

ResMed, figure by figure

ResMed (RMD) overview: price, valuation and scorecardAll health care companies by market value

ResMed net assets (shareholders' equity): questions and answers

What are ResMed's net assets?

ResMed (RMD) had net assets of $6.59B at the end of fiscal 2026 (June 30, 2026). That is 10.3% higher than the $5.97B of fiscal 2025.

What is the growth rate of ResMed's net assets?

Over the five fiscal years to 2026 net assets grew at a compound 17.9% a year; over ten years the rate was 14.5% a year.

What are the highest and lowest net assets figures on record for ResMed?

Across the 18 fiscal years on record (2009–2026), the highest was $6.59B in fiscal 2026 and the lowest $1.12B in fiscal 2009.

How is ResMed's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For ResMed it is on record here for 18 fiscal years, 2009 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ResMed (RMD) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/RMD/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.